defy routine.

Read about what’s going on in our network.

The next-gen leaders of enterprise venture capital think software is going to look much different post-pandemic. Here are their predictions for what’s ahead

“Digital-first workflows that truly automate and connect people across physical boundaries are likely to be big opportunities in software in the next 6-12 months,” Defy Partners senior associate Madison McIlwain said. “Now, more than ever before, people are going to ask the question, ‘Can’t we do this digitally?”‘ Enterprise investors should be seeking opportunities to…

Read more
Human Proteome Company Nautilus Biotechnology Raises $76 Million

Nautilus Biotechnology, a company that is pioneering high-throughput and low-cost platform for analyzing and quantifying the human proteome, announced it has raised $76 million

Read more
download (1)
Nautilus emerges with $76M to become the ‘Illumina of proteomics’

Nautilus is uncloaking with a $76 million series B round to do for proteomics—the study of proteins—what companies like Illumnina did for genomics.

Read more
Nautilus Biotechnology Raises $76 Million in Series B Funding to Be the First to Quantify the Human Proteome

Nautilus Biotechnology, a company pioneering a high-throughput, low-cost platform for analyzing and quantifying the human proteome, today announced it has raised $76 million in an oversubscribed Series B offering that closed on Monday, May 18, 2020. Nautilus’ total funding now exceeds $100 million.

Read more
Jeff Bezos’s Family Office Bets on Startup Mapping Human Proteins

Nautilus Biotechnology has raised $76 million to help find ways to treat diseases like cancer and multiple sclerosis.

Read more